ライフサイエンスコーパス: psychoactive

1 tivation of the human PXR by hyperforin, the psychoactive agent in St. John's wort.

2 However, most psychoactive agents act on multiple neurotransmitters, l

3 These transporters interact with multiple psychoactive agents including cocaine, amphetamines and

4 norepinephrine (NET) are targets of multiple psychoactive agents, and their dysfunction has been impl

5 lease and are important targets for multiple psychoactive agents, including amphetamines, cocaine, an

6 targets for a number of clinically relevant psychoactive agents, including antidepressants, cocaine,

7 partly because it is the target of multiple psychoactive agents, including the antidepressant paroxe

8 gaine, a hallucinogenic natural product with psychoactive and anti-addictive properties(13,14).

9 d other cannabinoids are responsible for the psychoactive and medicinal properties of Cannabis sativa

10 d type 1 (CB1) receptor mediates marijuana's psychoactive and reinforcing properties.

11 Acute NPS toxicity includes significant psychoactive and sympathomimetic effects.

12 Our findings indicate that these 428 psychoactives are among the top-ranked predictions for a

13 The abuse of psychoactive 'bath salts' containing cathinones such as

14 ed changes in Gi and Gq activity predict the psychoactive behavioral effects of a variety of pharmoco

15 Increasing evidence suggests that psychoactive cannabinoid use in adolescence enhances the

16 Under on-chip exposure to the psychoactive cannabinoid, Delta-9-tetrahydrocannabinol (

17 In contrast to other psychoactive cathinones (eg, mephedrone), MDPV is not a

18 ht mass spectrometer (APIM(tof)MS) to detect psychoactive cathinones and tryptamines from aqueous pha

19 et of Delta(9)-tetrahydrocannabinol (THC), a psychoactive chemical from Cannabis sativa with a wide r

20 s widely believed that cannabis, or its main psychoactive component Delta(9)-tetrahydrocannabinol (TH

21 Delta(9)-tetrahydrocannabinol (THC), a major psychoactive component found in marijuana or anandamide,

22 tetrahydrocannabinol (Delta9-THC), the major psychoactive component in marijuana, can lead to enhance

23 iangle up(9)-tetrahydrocannabinol (THC), the psychoactive component in marijuana.

24 at in mice, subchronic administration of the psychoactive component of cannabis, delta9-tetrahydrocan

25 re to Delta(9)-tetrahydrocannabinol (THC), a psychoactive component of cannabis, on the morphological

26 trahydrocannabinol (Delta(9)-THC), the major psychoactive component of cannabis, produced dose-depend

27 elta(9)-tetrahydrocannabinol (THC), the main psychoactive component of cannabis, results in behaviora

28 e to delta-9-tetrahydrocannabinol, the major psychoactive component of cannabis, with protracted effe

29 -9-tetrahydrocannabinol (THC) is the primary psychoactive component of cannabis.

30 Nicotine, the major psychoactive component of cigarette smoke, modulates neu

31 elta(9)-tetrahydrocannabinol (THC), the main psychoactive component of marijuana (Cannabis sativa), i

32 Delta(9)-tetrahydrocannabinol (THC), a major psychoactive component of marijuana, and AEA.

33 Delta(9)-tetrahydrocannabinol (THC), the psychoactive component of marijuana, and other direct ca

34 m, most popularly known as the target of the psychoactive component of marijuana, Delta(9)-tetrahydro

35 s capable of oxidatively degrading the major psychoactive component of marijuana, Delta9-tetrahydroca

36 etrahydrocannabinol (Delta(9)-THC), the main psychoactive component of marijuana, is known to dysregu

37 Delta9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, is toxic for hippoc

38 elta-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, suppresses host imm

39 Cannabidiol (CBD) is a non-psychoactive component of marijuana, which has anti-infl

40 by Delta(9)-tetrahydrocannabinol (THC), the psychoactive component of marijuana.

41 thylenedioxymethamphetamine (MDMA), the main psychoactive component of the recreational drug ecstasy,

42 Nicotine, the main psychoactive component of tobacco, and (-)-Delta(9)-tetr

43 lta(9)-tetrahydrocannabinol, one of the main psychoactive components of marijuana.

44 changes primarily involve an increase of the psychoactive compound (9)-tetrahydrocannabinol (THC) and

45 caffeine (CAF) is the most commonly consumed psychoactive compound by humans.

46 o known as marijuana or hemp, produces a non-psychoactive compound cannabidiol (CBD).

47 -9-tetrahydrocannabinol (THC) is the primary psychoactive compound in Cannabis, which is studied exte

48 The main psychoactive compound in marijuana, Delta(9)-tetrahydroc

49 tetrahydrocannabinol (Delta9-THC), the major psychoactive compound in marijuana.

50 Cannabidiol (CBD), the non-psychoactive compound isolated from cannabis plants, was

51 trahydrocannabinol (THC), the most prominent psychoactive compound of marijuana, plays a crucial regu

52 in detecting the primary and the most sought psychoactive compound tetrahydrocannabinol (THC) in mari

53 ling studies suggest why the closely-related psychoactive compound tetrahydrocannabinol may not have

54 cs oxantel pamoate and pyrantel pamoate; the psychoactive compounds hydroxyzine pamoate (Vistaril) an

55 The protocol is also a tool for testing psychoactive compounds in the context of a vertebrate br

56 ts possible role in the in vivo synthesis of psychoactive compounds or neurotoxins and has been chara

57 edict putative therapeutic properties of 428 psychoactive compounds that belong to the phenylethylami

58 of fast-acting antidepressants and possibly psychoactive compounds with effectiveness against other

59 The psychoactive constituent in cannabis, Delta(9)-tetrahydr

60 ahydocannabinol (THC+ status), the principal psychoactive constituent in cannabis, was associated wit

61 of delta-9-tetrahydrocannabinol, the primary psychoactive constituent in cannabis.

62 Given that the psychoactive constituent of cannabis binds to the CB1 ca

63 The discovery of the main psychoactive constituent of Cannabis sativa L., Delta(9)

64 elta(9)-tetrahydrocannabinol (THC), the main psychoactive constituent of cannabis, affects body weigh

65 The psychoactive constituent of cannabis, Delta(9)-tetrahydr

66 Rats were exposed to THC, the main psychoactive constituent of cannabis, for 3 days (two in

67 -Delta9-tetrahydrocannabinol (THC; the major psychoactive constituent of marijuana), due to enhanced

68 The main psychoactive constituent of marijuana, (-)-Delta(9)-tetr

69 eptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agoni

70 ta(9)-tetrahydrocannabinol (Delta(9)-THC), a psychoactive constituent that activates cannabinoid CB(1

71 elta(9)-tetrahydrocannabinol, the main plant psychoactive constituent, activate both cannabinoid rece

72 pairs memory through interaction between its psychoactive constituent, Delta-9-tetrahydrocannabinol (

73 The rewarding properties of the psychoactive constituents of marijuana, termed "cannabin

74 g 1, 1992, and June 30, 1995, and had used a psychoactive drug (tricyclic antidepressant, benzodiazep

75 The psychoactive drug +/-3,4-methylenedioxymethamphetamine (

76 ctive serotonin-reuptake inhibitor, or other psychoactive drug [mainly major tranquillisers]) between

77 Caffeine, the most commonly ingested psychoactive drug and a nonselective adenosine receptor

78 The psychoactive drug caffeine influences neuronal physiolog

79 es), distinguish the pyrrolidones from other psychoactive drug classes.

80 untary consumption of edibles containing the psychoactive drug Delta(9)-tetrahydrocannabinol (THC).

81 te (Ritalin) is the most commonly prescribed psychoactive drug in children for the treatment of atten

82 ormone response to stimuli associated with a psychoactive drug in rats and suggest that the effect is

83 Caffeine is the most widely-consumed psychoactive drug in the world, but our understanding of

84 Nicotine, the main psychoactive drug in tobacco, is one of the most heavily

85 lowered by amphetamine, indicating that the psychoactive drug induced a conditioned reduction in tas

86 report on the antimicrobial activity of the psychoactive drug metergoline, which is specific against

87 domide ([+]-alpha-phthalimidoglutarimide), a psychoactive drug that readily crosses the blood-brain b

88 Thalidomide, a psychoactive drug that readily crosses the blood-brain b

89 about current and past church attendance and psychoactive drug use.

90 s outweighed by that of a highly reinforcing psychoactive drug.

91 odiazepines (1.62 [1.24-2.12]), and 47 other psychoactive drugs (0.88 [0.62-1.25]).

92 or dependence was the highest for prescribed psychoactive drugs (hazards ratio, 13.0; 95% confidence

93 d in laboratory animals for almost all other psychoactive drugs abused by humans, as well as for nico

94 ities elicited by a panel of neuroactive and psychoactive drugs administered to a cohort of nearly 70

95 Among the psychoactive drugs analyzed, the median environmental em

96 Pure psychoactive drugs and direct routes of administration a

97 examined the association between the use of psychoactive drugs and road-traffic accidents.

98 duced neuroadaptations and demonstrates that psychoactive drugs and stress trigger divergent changes

99 Self-medication for pain with psychoactive drugs appears especially problematic among

100 ters that are the molecular targets for such psychoactive drugs as cocaine, amphetamines, and therape

101 rce of durable fibers, nutritious seeds, and psychoactive drugs but few economic plants are so poorly

102 Currently available psychoactive drugs exert their effects through 3 or 4 of

103 neral therapeutic classes into which various psychoactive drugs fall, based on high-content statistic

104 cher (F344) inbred rat strains to stress and psychoactive drugs have been related to differences in t

105 se and abuse of most other licit and illicit psychoactive drugs have been shown to be substantially h

106 tor studies suggest that commonly prescribed psychoactive drugs impair driving skills.

107 can contribute to the regulation of mood by psychoactive drugs in mental illnesses such as bipolar d

108 The median concentrations of psychoactive drugs in sludge from domestic WWTPs were 1.

109 ention time can affect the concentrations of psychoactive drugs in sludge.

110 tem and is a site of action for a variety of psychoactive drugs including antidepressants, amphetamin

111 convincingly provided in vivo evidence that psychoactive drugs increase dopamine (DA) levels in huma

112 A major obstacle for the discovery of psychoactive drugs is the inability to predict how small

113 on of the cellular and behavioral effects of psychoactive drugs of abuse, we developed Cre/loxP condi

114 Little is known about the acute effects of psychoactive drugs on impulsivity and decision making in

115 ges in mental states such as those caused by psychoactive drugs relies on clinical assessments that a

116 be involved in the regulation of behavior by psychoactive drugs such as antipsychotics and mood stabi

117 is rats show greater behavioral responses to psychoactive drugs than Fischer rats and they fail to sh

118 nicotine, cocaine, or amphetamine, which are psychoactive drugs that induce well-documented neuroadap

119 emission rates of some of the metabolites of psychoactive drugs through WWTP discharges were higher t

120 inquiry through the acute administration of psychoactive drugs to patients with serious mental illne

121 of death were tuberculosis, opioid use, HIV, psychoactive drugs use, viral hepatitis, and obesity, ea

122 A high increase in the use of psychoactive drugs was detected between 2010 and 2014, e

123 Psychoactive drugs with minimal abuse potential do not c

124 metabolic variations, medical comorbidities, psychoactive drugs, alcohol use, mental state) tend to v

125 he determination of common legal and illegal psychoactive drugs, and major metabolites, in breast mil

126 iffer in the initial, reinforcing effects of psychoactive drugs, but not in responses seen after the

127 titute the principal sites of action of many psychoactive drugs, including amphetamines and cocaine,

128 Several psychoactive drugs, including antidepressants, can modul

129 ilieu and is potently inhibited by number of psychoactive drugs, including cocaine, amphetamines, and

130 evious findings with other licit and illicit psychoactive drugs, individual differences in caffeine u

131 KC is a target for the therapeutic action of psychoactive drugs, our findings indicate that the patho

132 fluences of emotionality, thought speed, and psychoactive drugs--and atypical differences in individu

133 ng, motivated behaviors, and even seeking of psychoactive drugs.

134 is one of the most commonly and widely used psychoactive drugs.

135 control signaling pathways targeted by many psychoactive drugs.

136 isease, neurosurgical procedures, and use of psychoactive drugs.

137 y microarray studies in animals administered psychoactive drugs.

138 gesting behavioral synergism between the two psychoactive drugs.

139 tanding platelet function and the effects of psychoactive drugs.

140 ed as a basis for decisions about the use of psychoactive drugs.

141 ronmental factors modulate responsiveness to psychoactive drugs.

142 r in behavioral and biochemical responses to psychoactive drugs: Lewis rats show greater behavioral r

143 the circulating drug, thus terminating both psychoactive effects and drug toxicity.

144 While its psychoactive effects are mainly associated with GABAergi

145 Hallucinogens mediate many of their psychoactive effects by activating serotonin 2A receptor

146 not A-NK-amide, showed acute and persisting psychoactive effects in mice.

147 ly consumed behavioral drug caffeine, as the psychoactive effects of caffeine are mediated largely by

148 THC is thought to produce the main psychoactive effects of cannabis, while CBD does not app

149 (decreased) animals, which suggests that the psychoactive effects of cocaine are influenced by the st

150 -steroid hormone estradiol (E2) enhances the psychoactive effects of cocaine, as evidenced by clinica

151 of the phage-displayed proteins to block the psychoactive effects of cocaine.

152 1) cannabinoid receptor mediates many of the psychoactive effects of Delta(9)THC, the principal activ

153 approach, called DISSECTIV, to mitigate the psychoactive effects of fenethylline and show that its r

154 an effective immunotherapy for reducing the psychoactive effects of fentanyl class drugs.

155 tly neurogenesis by overcoming the undesired psychoactive effects of neuronal CB(1) cannabinoid recep

156 g site for cocaine and other stimulants, the psychoactive effects of which are associated primarily w

157 tween these two metabolites cause Captagon's psychoactive effects to act faster and far more potently

158 ol (CBD), a constituent of cannabis with few psychoactive effects, has been reported in some studies

159 nol, have been studied extensively for their psychoactive effects, it has become apparent that certai

160 DA receptors (NMDARs) may trigger ketamine's psychoactive effects, ketamine or its major metabolite n

161 ral) cannabinoid receptors should be free of psychoactive effects, perhaps allowing for more effectiv

162 iscussed, with particular reference to their psychoactive effects.

163 cetylcholine receptors (nAChRs) to exert its psychoactive effects.

164 crush the pills and smoke the powder for its psychoactive effects.

165 uppressive properties while demonstrating no psychoactive effects.

166 treatment of acute and chronic pain without psychoactive effects.

167 crease the enzyme's ability to hydrolyze the psychoactive enantiomer of cocaine.

168 e include the conversion of cocaine to a non-psychoactive form, the degradation of nicotine, activati

169 hesized in 1938 and identified as (potently) psychoactive in 1943.

170 Ibogaine (Endabuse) is a psychoactive indole alkaloid found in the shrub, Taberna

171 Ibogaine (Endabuse) is a psychoactive indole alkaloid found in the West African s

172 elta(9)-tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, are a pressing conc

173 a(9)-tetrahydrocannabinol (THC), the primary psychoactive ingredient in cannabis, are believed to be

174 tetrahydrocannabinol (Delta9-THC), the major psychoactive ingredient in cannabis, causes fetal growth

175 The primary psychoactive ingredient in cannabis, Delta9-tetrahydroca

176 nnabinol (Delta9-THC; 1.19 mg/2 ml), the key psychoactive ingredient in cannabis, in a set of 16 heal

177 elta(9)-tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, play major roles in

178 9)-tetrahydrocannabinol (THC), the principal psychoactive ingredient in marijuana, acts as a partial

179 The principal psychoactive ingredient in marijuana, Delta(9)-tetrahydr

180 with delta-9-tetrahydrocannabinol (THC), the psychoactive ingredient in marijuana, have been unsucces

181 of Delta9-tetrahydrocannabinol, the primary psychoactive ingredient in marijuana, whereas S1P recept

182 elta(9)-tetrahydrocannabinol (THC), the main psychoactive ingredient in marijuana.

183 ydrocannabinol (Delta9-THC) is the principal psychoactive ingredient in marijuana.

184 Tetrahydrocannabinol (Delta9-THC), the major psychoactive ingredient in preparations of Cannabis sati

185 Nicotine, the psychoactive ingredient in tobacco, can be neuroprotecti

186 used by humans, as well as for nicotine, the psychoactive ingredient in tobacco, these studies would

187 ivated by Delta(9)-tetrahydrocannabinol, the psychoactive ingredient of cannabis, and mediate physiol

188 ound that Delta(9)-tetrahydrocannabinol, the psychoactive ingredient of cannabis, disrupts autophagy

189 tetrahydrocannabinol (delta-9-THC), the main psychoactive ingredient of cannabis, on anxiety and on a

190 elta-9-tetrahydrocannabinol (THC), a primary psychoactive ingredient of marijuana, affects locomotor

191 Single injections with the main psychoactive ingredient of marijuana, Delta(9)-tetrahydr

192 Nicotine, the main psychoactive ingredient of tobacco smoke, induces negati

193 Nicotine, the main psychoactive ingredient of tobacco, induces negative emo

194 tetrahydrocannabinol (THC), marijuana's main psychoactive ingredient.

195 ein-coupled receptor (GPCR) triggered by the psychoactive ingredients in marijuana, as well as endoge

196 Muscimol is a psychoactive isoxazole derived from the mushroom Amanita

197 The only other psychoactive medication allowed was lorazepam for agitat

198 racteristics such as severity, duration, and psychoactive medication do further impact on biological

199 es (r = 0.91, P<.001), quantity of different psychoactive medication dosages 8 hours prior to assessm

200 Risk of new psychoactive medication prescriptions was also increased

201 rformance, cognitive dysfunction, as well as psychoactive medication use are significantly associated

202 tical illness, new psychiatric diagnoses and psychoactive medication use is increased in the months a

203 nder, dementia stage, function, comorbidity, psychoactive medication use) and nesting effects of resi

204 d documented psychiatric history or received psychoactive medication within 30 days before entering t

205 e history, and psychiatric history or recent psychoactive medication.

206 psychiatric illnesses and prescriptions for psychoactive medications in the 5 years before critical

207 enduring effects have been observed for the psychoactive medications, which appear to be largely pal

208 nted for age, sex, adiposity, and the use of psychoactive medications.

209 at creates antibodies against heroin and its psychoactive metabolites by presenting multihaptenic str

210 n the immune response against heroin and its psychoactive metabolites.

211 The street drug "bath salts" are psychoactive mixtures of cathinone derivatives.

212 onse but one against heroin and its multiple psychoactive molecules.

213 tic target, as it is metabolized to multiple psychoactive molecules.

214 re we report that serotonin differs from the psychoactive N-methyltryptamines by its ability to engag

215 Salvinorin A is a psychoactive natural product that has been found to be a

216 CBD, which alone produced no significant psychoactive or cardiovascular effects, did not signific

217 A total of 16 psychoactive pharmaceuticals (0.12-460 ng/g dry weight)

218 This study draws upon a nationwide survey of psychoactive pharmaceuticals (i.e., antischizophrenics,

219 spinach accumulation and metabolism of four psychoactive pharmaceuticals found in reclaimed wastewat

220 vity contingent upon the administration of a psychoactive pharmacological agent has been demonstrated

221 provides an opportunity to study the use of psychoactive plants in the past and to better understand

222 of puparial casings; (4) distinguish between psychoactive plants products; and (5) differentiate betw

223 Five-year preadmission psychoactive prescription rates were similar to hospital

224 e and show that its rapid-onset and distinct psychoactive properties are facilitated by functional sy

225 d in traditional spiritual practices for its psychoactive properties by the Mazatecs of Oaxaca, Mexic

226 Although the psychoactive properties of fenethylline have been report

227 AR agonists such as lisuride lack comparable psychoactive properties.

228 America have been used for their healing and psychoactive properties.

229 -like hallucinations, while others lack this psychoactive property entirely.

230 receptor agonists remain limited because of psychoactive side effects.

231 ity for CB1 and CB2 receptors nor with their psychoactive side effects.

232 Moreover, THC produces motor and psychoactive side effects.

233 cts but are also associated with undesirable psychoactive side effects.

234 e because of the dose limitations imposed by psychoactive side effects.

235 The psychoactive stimulant 3, 4-methylenedioxymethamphetamin

236 n by the trade name Captagon, is a synthetic psychoactive stimulant that has recently been linked to

237 Psychoactive stimulants that activate the dopamine D(1)

238 ot applicable to detect an alarming array of psychoactive stimulants, tranquilizers, and synthetic op

239 ettes to facilitate covert use of a range of psychoactive stimulants.

240 rain by chronic exposure to several types of psychoactive stimuli, including drugs of abuse, stress,

241 psychiatric diagnostic categories assessed, psychoactive substance abuse conferred the highest risk

242 dioxy-N-methylcathinone (methylone) is a new psychoactive substance and the beta-keto analog of 3,4-m

243 f genetic and environmental risk factors for psychoactive substance dependence was similar in males a

244 Caffeine is the most widely consumed psychoactive substance in the world and presents with wi

245 Nicotine is the primary psychoactive substance in tobacco, and it exerts its eff

246 tic factors are important in the etiology of psychoactive substance use (PSU), we know little of how

247 %; alcohol dependence, 11.2%; and nonalcohol psychoactive substance use dependence, 15.2%.

248 t 12-month alcohol dependence and nonalcohol psychoactive substance use dependence.

249 on deficit hyperactivity disorder (ADHD) and psychoactive substance use disorder (alcohol or drug abu

250 rame were highest in people diagnosed with a psychoactive substance use disorder at first discharge (

251 s were more likely to receive a diagnosis of psychoactive substance use disorder but no other psychia

252 he criteria for an anxiety disorder, 60% for psychoactive substance use disorder, 53% for another par

253 he risks in first-degree relatives for ADHD, psychoactive substance use disorder, alcohol dependence,

254 t patients with concurrent schizophrenia and psychoactive substance use disorders may be adequately t

255 aches to prevention and treatment of illicit psychoactive substance use, abuse, and dependence, we ne

256 Cannabis is the most frequently used illicit psychoactive substance worldwide; around one in ten user

257 The electrochemical sensing of new psychoactive substance(s) (NPSs), synthetic cathinone de

258 Caffeine is the most commonly used psychoactive substance, and consumption by adolescents h

259 Caffeine is a widely consumed psychoactive substance, but little is known about the ef

260 ion of A(1)AR by caffeine, a widely consumed psychoactive substance, could antagonize the endogenous

261 Caffeine, the most widely consumed psychoactive substance, produces complex pharmacological

262 the influence of cannabis, specifically the psychoactive substance, tetrahydrocannabinol (THC).

263 Caffeine is an addictive psychoactive substance.

264 affeine is by far the most commonly consumed psychoactive substance.

265 SCs) continue to be the largest group of new psychoactive substances (NPS) monitored by the European

266 A few new psychoactive substances (NPS) that mimic the effects of

267 ise the third largest number of reported new psychoactive substances (NPS), according to the United N

268 c cathinones are among the most consumed new psychoactive substances (NPS), but their increasing numb

269 been applied for the identification of novel psychoactive substances (NPS).

270 exchange has been used to characterize novel psychoactive substances (NPSs) which are small synthetic

271 ide, cannabis is one of the most widely used psychoactive substances and cannabis use has been implic

272 As novel psychoactive substances appeared in Europe, they should

273 enetic risk factors for dependence on common psychoactive substances cannot be explained by a single

274 New psychoactive substances constitute a growing and dynamic

275 The abuse of synthetic psychoactive substances known as "designer drugs," or "n

276 neral physiological and cognitive effects of psychoactive substances or psychopathological conditions

277 individuals will use or misuse one class of psychoactive substances rather than another.

278 New psychoactive substances refer to emerging substances tha

279 ubstances known as "designer drugs," or "new psychoactive substances" (NPS), is increasing at an alar

280 on level use of licit and illicit drugs, new psychoactive substances, human exposure to a wide range

281 amine (DAT) are prominent targets of various psychoactive substances, including competitive inhibitor

282 Other psychoactive substances, such as increasingly prescribed

283 The electrochemical sensing of new psychoactive substances, synthetic cannabinoids (SCs), c

284 s are often sufficient for identifying novel psychoactive substances, they may not readily differenti

285 f demographic variables and the use of other psychoactive substances, we found that psychedelic subst

286 bute to dependence on both licit and illicit psychoactive substances, we know little of how these ris

287 mind-altering compounds, also known as "new psychoactive substances," is increasing globally at an a

288 Europe by the EU Early Warning System on new psychoactive substances.

289 s (SCs) are among the most commonly used new psychoactive substances.

290 btained from a single instrument run for the psychoactive substances.

291 and families and exposure to other prenatal psychoactive substances.

292 available and one of the most commonly used psychoactive substances.

293 vely, had current diagnoses of dependence on psychoactive substances.

294 rugs (pragmatically clustered and termed new psychoactive substances; [NPS]) has challenged tradition

295 bogaine and (-)-voacangine are plant derived psychoactives that show promise as treatments for opioid

296 species that converted L-Phe into the potent psychoactive trace amine phenethylamine, which crosses t

297 In patients without psychoactive treatment (n = 101), the incidence of falls

298 Patients taking psychoactive treatment (n = 21) had a higher frequency o

299 These findings show that, like several other psychoactive treatments, repeated rTMS sessions can exer

300 cribe how toluene, the most commonly studied psychoactive volatile solvent, alters synaptic transmiss